Jump to section
IdentificationPharmacologyInteractionsReferencesTrialsEconomicsPropertiesSpectraTaxonomyBenzylpenicilloyl Polylysine
Identification
- Name
- Benzylpenicilloyl Polylysine
- Accession Number
- DB00895 (APRD00822)
- Type
- Small Molecule
- Groups
- Approved
- Description
Benzylpenicilloyl Polylysine is used as a skin-testing reagent to detect immunoglobulin E antibodies in people with a history of penicillin allergy. The quantitation of in vitro IgE antibodies to the benzylpenicilloyl determinant is a useful tool for evaluating allergic subjects.
- Structure
Structure for Benzylpenicilloyl Polylysine (DB00895)
- Synonyms
- Benzyl penicilloyl-polylysine
- Benzylpenicilloyl G polylysine
- Benzylpenicilloyl-polylysine
- Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Pre-pen Solution 0.000060 m Intradermal Alk Abello, Inc. 1975-12-31 Not applicable Canada 
Pre-pen Injection 60 umol/0.25mL Intradermal; Subcutaneous Aller Quest Llc 1974-07-25 Not applicable US 
- Categories
- Acetamides
- Acetates
- Acids, Acyclic
- Amides
- Anti-Bacterial Agents
- Antibacterials for Systemic Use
- Antiinfectives for Systemic Use
- Aza Compounds
- Azabicyclo Compounds
- Benzene Derivatives
- Beta-Lactam Antibacterials, Penicillins
- beta-Lactams
- Drug Hypersensitivity
- Fatty Acids
- Fatty Acids, Volatile
- Lactams
- Lipids
- Penicillins
- Sulfur Compounds
- UNII
- 76479814OY
- CAS number
- 31855-75-1
- Weight
- Average: 626.765
Monoisotopic: 626.309783168 - Chemical Formula
- C28H46N6O8S
- InChI Key
- IMPVZRLKKKXMKQ-SGDOCVTFSA-N
- InChI
- InChI=1S/C22H32N4O6S.C6H14N2O2/c1-22(2)17(21(31)32)26-19(33-22)16(25-15(27)12-13-8-4-3-5-9-13)18(28)24-11-7-6-10-14(23)20(29)30;7-4-2-1-3-5(8)6(9)10/h3-5,8-9,14,16-17,19,26H,6-7,10-12,23H2,1-2H3,(H,24,28)(H,25,27)(H,29,30)(H,31,32);5H,1-4,7-8H2,(H,9,10)/t14-,16?,17+,19-;5-/m11/s1
- IUPAC Name
- SMILES
Pharmacology
- Indication
For use as a adjunct in assessing the risk of administering penicillin (benzylpenicillin or penicillin G).
- Associated Conditions
- Pharmacodynamics
Benylpenicilloyl polylysine is penicilloyl bound to polylysine and is considered to be the major determinant of penicillin metabolism; it is used as a skin-testing reagent to detect immunoglobulin E antibodies in people with a history of penicillin allergy. If skin testing using benzylpenicilloyl and penicillin G (as the sole source of minor determinants) is negative, approximately 97% of patients with a negative skin test will tolerate penicillin.
- Mechanism of action
The skin test for penicillin demonstrates the presence or absence of specific IgE antibodies to major and minor penicillin determinants. IgE antibodies to major determinants can be detected by using benzylpenicilloyl polylysine. A penicillin skin test predicts only the presence of IgE antibodies for the major or minor penicillin determinants at the time of application and does not predict the future development of IgE-mediated reactions during subsequent courses of penicillin. Benzylpenicilloyl polylysine reacts specifically with penicilloyl skin sensitizing antibodies (reagins) to produce immediate wheal and flare reactions which may reflect increased risk of allergic reactions to subsequent penicillin therapy.
Target Actions Organism AHigh affinity immunoglobulin epsilon receptor subunit gamma agonistHuman AHigh affinity immunoglobulin epsilon receptor subunit alpha agonistHuman - Absorption
- Not Available
- Volume of distribution
- Not Available
- Protein binding
- Not Available
- Metabolism
- Not Available
- Route of elimination
- Not Available
- Half life
- Not Available
- Clearance
- Not Available
- Toxicity
Symptoms of overdose include urticaria, generalized pruritus, local swelling, generalized flushing, anaphylaxis, bronchospasm, fainting and maculopapular eruption.
- Affected organisms
- Humans and other mammals
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
Drug Interaction (R)-warfarin Benzylpenicilloyl Polylysine may increase the anticoagulant activities of (R)-warfarin. (S)-Warfarin Benzylpenicilloyl Polylysine may increase the anticoagulant activities of (S)-Warfarin. 4-hydroxycoumarin Benzylpenicilloyl Polylysine may increase the anticoagulant activities of 4-hydroxycoumarin. 4-Methoxyamphetamine 4-Methoxyamphetamine may decrease effectiveness of Benzylpenicilloyl Polylysine as a diagnostic agent. Abediterol Abediterol may decrease effectiveness of Benzylpenicilloyl Polylysine as a diagnostic agent. Acemetacin Acemetacin may decrease the excretion rate of Benzylpenicilloyl Polylysine which could result in a higher serum level. Acenocoumarol Benzylpenicilloyl Polylysine may increase the anticoagulant activities of Acenocoumarol. Aceprometazine Aceprometazine may decrease effectiveness of Benzylpenicilloyl Polylysine as a diagnostic agent. Acrivastine Acrivastine may decrease effectiveness of Benzylpenicilloyl Polylysine as a diagnostic agent. Adrafinil Adrafinil may decrease effectiveness of Benzylpenicilloyl Polylysine as a diagnostic agent. - Food Interactions
- Not Available
References
- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0015032
- PubChem Compound
- 45266800
- PubChem Substance
- 46505002
- ChemSpider
- 26331550
- ChEBI
- 59297
- ChEMBL
- CHEMBL1201779
- Therapeutic Targets Database
- DAP001314
- PharmGKB
- PA164754810
- Wikipedia
- Benzylpenicilloyl_polylysine
- ATC Codes
- J01CR50 — Combinations of penicillins
- AHFS Codes
- 36:30.00 — Drug Hypersensitivity
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 3 Completed Diagnostic History of IgE Dependent Reaction to a Penicillin Product 1
Pharmacoeconomics
- Manufacturers
- Allerquest llc
- Packagers
- Allerquest LLC
- Schwarz Pharma Inc.
- Taylor Pharmaceuticals
- Dosage forms
Form Route Strength Injection Intradermal; Subcutaneous 60 umol/0.25mL Solution Intradermal 0.000060 m - Prices
Unit description Cost Unit Pre-pen ampul 72.0USD ampul DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
Property Value Source logP -0.8 Not Available - Predicted Properties
Property Value Source Water Solubility 0.0658 mg/mL ALOGPS logP -0.89 ALOGPS logP -3.8 ChemAxon logS -3.9 ALOGPS pKa (Strongest Acidic) 2.04 ChemAxon pKa (Strongest Basic) 9.53 ChemAxon Physiological Charge 0 ChemAxon Hydrogen Acceptor Count 8 ChemAxon Hydrogen Donor Count 6 ChemAxon Polar Surface Area 170.85 Å2 ChemAxon Rotatable Bond Count 17 ChemAxon Refractivity 122.22 m3·mol-1 ChemAxon Polarizability 50.31 Å3 ChemAxon Number of Rings 2 ChemAxon Bioavailability 0 ChemAxon Rule of Five No ChemAxon Ghose Filter No ChemAxon Veber's Rule No ChemAxon MDDR-like Rule No ChemAxon - Predicted ADMET features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
Taxonomy
- Classification
- Not classified
Targets
- Kind
- Protein
- Organism
- Human
- Pharmacological action
- Yes
- Actions
- Agonist
- General Function
- Igg binding
- Specific Function
- Associates with a variety of FcR alpha chains to form a functional signaling complex. Regulates several aspects of the immune response. The gamma subunit has a critical role in allowing the IgE Fc ...
- Gene Name
- FCER1G
- Uniprot ID
- P30273
- Uniprot Name
- High affinity immunoglobulin epsilon receptor subunit gamma
- Molecular Weight
- 9667.355 Da
References
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423]
- Chandra RK, Joglekar SA, Tomas E: Penicillin allergy: anti-penicillin IgE antibodies and immediate hypersensitivity skin reactions employing major and minor determinants of penicillin. Arch Dis Child. 1980 Nov;55(11):857-60. [PubMed:7436456]
- Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352]
- Kind
- Protein
- Organism
- Human
- Pharmacological action
- Yes
- Actions
- Agonist
- General Function
- Ige receptor activity
- Specific Function
- Binds to the Fc region of immunoglobulins epsilon. High affinity receptor. Responsible for initiating the allergic response. Binding of allergen to receptor-bound IgE leads to cell activation and t...
- Gene Name
- FCER1A
- Uniprot ID
- P12319
- Uniprot Name
- High affinity immunoglobulin epsilon receptor subunit alpha
- Molecular Weight
- 29595.67 Da
References
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423]
- Chandra RK, Joglekar SA, Tomas E: Penicillin allergy: anti-penicillin IgE antibodies and immediate hypersensitivity skin reactions employing major and minor determinants of penicillin. Arch Dis Child. 1980 Nov;55(11):857-60. [PubMed:7436456]
- Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352]
Drug created on June 13, 2005 07:24 / Updated on October 16, 2018 08:32